Ossama Ashraf Ahmed

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

Sherief Abd‐Elsalam, Eslam Saber Esmail, Mai Khalaf et al. · American Journal of Tropical Medicine and Hygiene · 2020 · 137 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village

Ossama Ashraf Ahmed, Eslam Safwat, Mohamed O. Khalifa et al. · International Journal of Hepatology · 2018 · 89 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

RETRACTED ARTICLE: Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial

Sherief Abd‐Elsalam, Shaimaa Soliman, Eslam Saber Esmail et al. · Biological Trace Element Research · 2020 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

Ossama Ashraf Ahmed, Mohamed A. Elsebaey, Mohamed Hassan Ahmed Fouad et al. · Infection and Drug Resistance · 2018 · 61 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

Ossama Ashraf Ahmed, Hany H. Kaisar, Rehab Badawi et al. · Infection and Drug Resistance · 2018 · 40 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17